Jalmex Pharma Consultancy Opening Hours : Monday to Friday - 8 Am to 5 Pm
Jalmex Pharma Consultancy offers expert pharmaceutical advisory services in regulatory compliance, quality assurance, audit support, and inspection readiness. We help businesses build robust systems, reduce risk, and achieve sustainable growth through practical, customized solutions.
Documentation Services Comprehensive Pharmaceutical Documentation Solutions for Uganda's Regulatory Environment Jalmex Pharma Consultancy Limited specializes in developing, preparing, and managing the complete spectrum of pharmaceutical documentation required for regulatory compliance, product registration, and quality assurance in Uganda. Our documentation services ensure your pharmaceutical products and operations meet the exacting standards of the National Drug Authority (NDA) and international regulatory bodies.
The National Drug Authority requires comprehensive, accurately prepared documentation for every aspect of pharmaceutical operations, from product registration through manufacturing, distribution, and post-market surveillance. Poorly prepared documentation leads to registration delays, inspection failures, and costly compliance gaps.
We prepare complete Common Technical Document (CTD) format dossiers that meet NDA Uganda's requirements for marketing authorization of pharmaceutical products. Our dossier preparation services include:
Module 1: Administrative and Regional Information
• Application forms in prescribed NDA formats.
• Cover letters following NDA Appendix 1 specifications.
• Certificate of Pharmaceutical Product (CPP) in WHO format.
• GMP certificates and manufacturing site documentation.
• Local Technical Representative authorization documents.
• Patent status declarations.
• Product labeling, package inserts, and patient information leaflets in NDA-prescribed templates.
Module 2: Quality, Safety, and Efficacy Summaries
• Quality Overall Summary (QOS) in Microsoft Word format as required.
• Quality Information Summary (QIS) following NDA templates.
• Non-clinical and clinical overviews where applicable
• Bioequivalence Trial Information (BTIF) for generic products.
• Biopharmaceutical Classification System (BCS) documentation and biowaiver applications.
Module 3: Quality Documentation
• Drug substance characterization and manufacturing information
• Finished product specifications and analytical methods
• Stability data supporting shelf-life claims for tropical climatic zones.
• Certificate of Analysis (CoA) for batch quality verification.
• Packaging material specifications and compatibility studies
Modules 4 & 5: Non-Clinical and Clinical Study Reports
• Pre-clinical pharmacology and toxicology summaries
• Clinical trial data and interchangeability studies for generics.
All dossiers are submitted in the exact format prescribed by NDA guidelines, with summaries in Word format and supporting data in searchable PDF with bookmarks and OCR readability.
Quality Management System SOPs
• Document control and record management.
• Change control procedures
• Deviation management and investigation
• Corrective and Preventive Actions (CAPA)
• Internal audit and self-inspection programs
• Supplier qualification and vendor management
• Product quality review procedures Manufacturing Operations SOPs
• Batch manufacturing and packaging procedures
• Equipment operation, cleaning, and maintenance
• Line clearance and product changeover
• In-process controls and sampling
• Yield reconciliation and material balance
• Batch numbering and status identification Quality Control Laboratory SOPs
• Sample receipt, storage, and retention
• Analytical method validation and verification
• Instrument calibration and qualification
• Reagent and reference standard management
• Out-of-specification (OOS) investigation
• Stability testing protocols Warehouse and Distribution SOPs
• Goods receipt and quarantine procedures
• Stock rotation and expiry management
• Temperature monitoring and cold chain management
• Dispatch and transportation controls
• Recall procedures and mock recalls
• Pest control and warehouse hygiene Facility and Personnel SOPs
• Personnel hygiene and gowning procedures
• Training and qualification programs
• Health screening and medical examinations
• Cleaning and sanitation schedules
• Environmental monitoring (for sterile operations)
• Waste management and disposal Each SOP includes clear purpose statements, scope definitions, responsibilities, step-by-step procedures, associated forms and records, and revision history—ensuring compliance with NDA's dual documentation categories of instructions and records/reports.
• Quality Policy and Quality Objectives: Clear statements of management commitment and measurable quality goals
• Organizational Structure: Quality unit organization charts with defined responsibilities and authorities
• Quality System Procedures: High-level procedures governing all quality system elements
• Management Review Processes: Scheduled reviews of quality system performance
• Resource Management: Documentation of personnel qualifications, facility adequacy, and equipment suitability
• Product Realization: Procedures covering the entire product lifecycle from development through distribution
• Measurement, Analysis, and Improvement: Systems for monitoring quality performance and driving continuous improvement Batch Manufacturing Records (BMRs) and Batch Packaging Records (BPRs) We design and implement batch records that ensure consistent, compliant production of every pharmaceutical batch: Batch Manufacturing Records Include:
• Product name, strength, and dosage form
• Batch number and planned batch size
• Bill of materials with approved suppliers
• Step-by-step manufacturing instructions with critical process parameters
• In-process control checkpoints with acceptance criteria
• Equipment identification and cleaning status verification
• Line clearance confirmations
• Yield calculations at each stage
• Deviation documentation spaces
• Operator and supervisor signatures with dates and times
• Quality Control release authorization Batch Packaging Records Include:
• Packaging materials specifications and quantities
• Labeling verification procedures
• Packaging line clearance documentation
• Reconciliation of printed packaging materials
• Sample retention documentation
• Final packaging inspection results Validation Documentation We prepare comprehensive validation master plans and individual validation protocols/reports required for GMP compliance: Validation Master Plan (VMP)
• Validation policy and objectives
• Organizational responsibilities
• Facility and system descriptions
• Validation approach and acceptance criteria
• Master validation schedule
• Change control linkage
• Documentation requirements Qualification Protocols and Reports
• Design Qualification (DQ): Documenting design meets user requirements and GMP
• Installation Qualification (IQ): Verifying correct installation per specifications
• Operational Qualification (OQ): Demonstrating operation across expected ranges
• Performance Qualification (PQ): Confirming consistent performance under load Process Validation Documentation
• Process validation protocols (prospective, concurrent, or retrospective approaches)
• Critical process parameter identification
• Process performance qualification (PPQ) reports
• Ongoing process verification programs
• Revalidation triggers and schedules Cleaning Validation Documentation
• Cleaning procedure validation protocols
• Acceptance limit calculations (health-based exposure limits, visual cleanliness)
• Sampling methods (swab, rinse) and locations
• Analytical method suitability
• Cleaning validation reports
• Carryover studies and worst-case product selection Analytical Method Validation Documentation
• Validation protocols covering specificity, accuracy, precision, linearity, range, LOD/LOQ, robustness
• Method validation reports with statistical analysis
• Method transfer protocols and reports
• Method verification for pharmacopoeial methods Drug Master Files (DMFs) For API manufacturers and excipient suppliers supporting pharmaceutical products in Uganda, we prepare comprehensive Drug Master Files in CTD format: Type II DMF (Drug Substance) Includes:
• Section 3.2.S.1: General information (nomenclature, structure, general properties).
• Section 3.2.S.2: Manufacture (manufacturers, process description, flow diagrams, process controls, process validation).
• Section 3.2.S.3: Characterization (elucidation of structure, impurities, physicochemical properties)
• Section 3.2.S.4: Control of Drug Substance (specifications, analytical procedures, validation, batch analysis, justification of specifications)
• Section 3.2.S.5: Reference Standards or Materials
• Section 3.2.S.6: Container Closure System
• Section 3.2.S.7: Stability (stability summary, post-approval stability protocol, stability data) All DMFs are prepared with proper transmittal letters, administrative information, and technical sections in the exact format required by regulatory authorities. Site Master Files (SMFs) We develop comprehensive Site Master Files providing detailed information about pharmaceutical manufacturing sites for regulatory submissions and inspections:
Site Master File Content:• Company contact information and site details
• Key personnel and organizational structure
• Description of manufacturing activities and product categories
• Personnel qualifications and training programs
• Premises and equipment descriptions with flow diagrams
• Quality management system overview
• Production and quality control operations
• Outsourced activities and contractor management
• Changes since last SMF submission
• Appendices (site plans, equipment lists, product lists, organizational charts) Technical Agreements and Contracts We draft and review technical agreements required for GMP compliance in outsourced activities:
• Contract Manufacturing Agreements: Defining quality responsibilities between contract giver and acceptor
• Contract Analysis Agreements: Outlining testing responsibilities and result reporting
• Contract Storage and Distribution Agreements: Ensuring product quality during warehousing and transport
• Quality Agreements: Detailed quality responsibility matrices for all outsourced operations
• Supplier Quality Agreements: Establishing quality expectations with raw material and packaging suppliers Regulatory Submission Documents Beyond product dossiers, we prepare all supporting documentation for regulatory interactions:
• Variations and Amendments: Documentation for post-approval changes (major, minor, notification)
• Renewal Applications: Complete renewal dossiers with updated stability data and quality reviews
• Response to Deficiency Letters: Technical responses addressing NDA queries during assessment
• Product Deregistration Notifications: Formal notifications for voluntary product withdrawals
• Import Permits and Supporting Documentation: Applications for import authorization of registered products
• Clinical Trial Applications: Investigational medicinal product documentation for clinical research Labeling and Patient Information Documentation We develop NDA-compliant labeling materials following prescribed templates:
• Package Inserts: Comprehensive prescribing information in NDA format
• Patient Information Leaflets (PILs): User-friendly patient counseling documents
• Primary Packaging Labels: Carton, bottle, blister, and sachet labels meeting NDA requirements
• Secondary Packaging: Outer carton designs with all mandatory declarations
• Mock-ups: Submission-ready label and leaflet mock-ups in prescribed formats
• Translations: Certified English translations for any non-English source documents as required by NDA. Stability Documentation We prepare comprehensive stability documentation supporting shelf-life claims for Uganda's tropical climate (Zone IVb):
• Stability Protocols: ICH Q1A-compliant protocols covering long-term, accelerated, and intermediate conditions
• Stability Summaries: Tabulated stability data with statistical analysis
• Shelf-Life Justifications: Scientific rationale for proposed expiry periods
• Storage Condition Statements: Clear labeling of required storage conditions
• In-Use Stability: Documentation for multi-dose products requiring beyond-use dating after opening
• Post-Approval Stability Commitments: Ongoing stability study protocols and annual updates Documentation Formatting and Submission Support We ensure your documentation meets NDA's exacting formatting requirements:
• Electronic Submission Preparation: CD-ROM submissions with proper directory structure and file naming
• PDF Optimization: Searchable PDFs with bookmarks, hyperlinks, and OCR readability
• Page Numbering: Consistent "page x of y" format throughout dossiers
• Index Development: Comprehensive indices for easy navigation of large dossiers
• Template Compliance: Use of exact NDA-prescribed templates for all required forms
• Translation Services: Certified translations of foreign-language documents with notarization where required. Our Documentation Quality Standards Accuracy and Compliance Every document we prepare undergoes rigorous technical review to ensure accuracy, completeness, and alignment with current NDA guidelines, EAC harmonized requirements, and international standards (ICH, WHO, PIC/S). Consistency and Traceability We maintain document consistency across your entire portfolio, with proper version control, revision histories, and traceability matrices linking requirements to documentation. Audit-Ready Quality Our documentation is prepared with inspection readiness in mind—clear, organized, and defensible during regulatory audits and assessments. Timely Delivery We understand that documentation delays directly impact your time-to-market. Our project management approach ensures documentation is delivered on schedule without compromising quality. Documentation Sectors We Support
• Human Pharmaceutical Products (solid oral, liquid, sterile, semi-solid dosage forms)
• Veterinary Pharmaceutical Products
• Active Pharmaceutical Ingredients (APIs)
• Herbal Medicines and Traditional Products
• Medical Devices and Diagnostics
• Cosmetics and Personal Care Products
• Nutraceuticals and Dietary Supplements. Our Documentation Process
1. Requirements Assessment: We begin by understanding your product, manufacturing process, and regulatory objectives
2. Gap Analysis: Existing documentation is reviewed against NDA requirements to identify gaps
3. Documentation Planning: A comprehensive documentation plan is developed with timelines and deliverables
4. Draft Development: Technical writers and pharmaceutical experts collaborate to create first drafts
5. Technical Review: Subject matter experts review for scientific accuracy and regulatory compliance
6. Client Review: Drafts are shared with your team for input and approval
7. Finalization: Documents are finalized with proper formatting, pagination, and electronic preparation
8. Submission Support: We assist with compilation and submission to regulatory authorities Confidentiality and Data Security We treat all client documentation with the highest level of confidentiality. Our team operates under strict non-disclosure agreements, and all documentation is handled through secure systems with controlled access—ensuring your intellectual property and proprietary information remain protected. Why Choose Jalmex Pharma for Documentation Services?
• Regulatory Expertise: Deep understanding of NDA Uganda requirements and international standards
• Technical Excellence: Team of qualified pharmacists, regulatory affairs specialists, and technical writers
• Proven Track Record: Successful registrations and inspections supported by our documentation
• Comprehensive Coverage: One-stop solution for all pharmaceutical documentation needs
• Quality Focus: Rigorous review processes ensuring first-time acceptance
• Cost Efficiency: Reduce internal resource burden while accelerating your regulatory timelines Contact Us Ready to strengthen your pharmaceutical documentation for the Ugandan market? Contact Jalmex Pharma Consultancy Limited today to discuss how our documentation expertise can support your regulatory success. Jalmex Pharma Consultancy Limited Your Partner in Pharmaceutical Documentation Excellence Kampala, Uganda
Gain practical experience in pharmaceutical product formulation in Uganda, from pre-formulation and prototype design to scale-up, bioequivalence studies, regulatory approval, and commercialization.
We bridge APIs with excipients to develop stable, effective dosage forms like tablets, capsules, creams, and lotions—optimized for patient needs and market success.
Simplify drug registration in Uganda with our dossier preparation in CTD format for submission to the National Drug Authority (NDA).
We ensure smooth approval and ongoing retention on the national drug register, helping your products launch faster.A registered pharmacist in Uganda and an experienced Industrial Pharmacist with over 7 years of expertise in pharmaceutical manufacturing. She graduated with a Bachelor's Degree in Pharmacy from Istanbul University, bringing strong technical knowledge to Jalmex Pharma Consultancy Limited.
Core Competencies
Dr. Amuge specializes in:
GMP compliance (Good Manufacturing Practice)
Quality Assurance (QA) & Quality Management Systems (QMS)
Production operations in pharmaceutical manufacturing
Regulatory support* for pharmaceutical manufacturers
Operational efficiency and product quality improvement Professional Impact She helps pharmaceutical manufacturers in Uganda and East Africa *enhance operational efficiency, elevate product quality, and maintain compliance with industry standards* including NDA, WHO, and international pharmaceutical requirements.
Anthony Aheebwa is a pharmacist and pharmaceutical quality professional based in Uganda, specializing in industrial pharmacy practice, regulatory affairs, and pharmaceutical quality systems. With extensive experience in Good Manufacturing Practice (GMP) implementation, he leads quality assurance and regulatory compliance initiatives across Uganda’s pharmaceutical sector.
Anthony’s expertise includes GMP-compliant quality systems, batch release oversight, document control, CAPA (corrective and preventive actions) management, risk assessment, self-inspections, and regulatory submissions.
He has supported multiple product pre-market authorizations and registrations with the National Drug Authority (NDA) and has played a pivotal role in strengthening operational and quality systems within pharmaceutical manufacturing environments. Trusted for delivering compliance-driven solutions, Anthony helps manufacturers meet regulatory requirements, improve product quality, and maintain continuous GMP compliance.
Muhamudu Lugolobi is an experienced pharmaceutical chemist with over 10 years in pharmaceutical manufacturing, specializing in technology transfer, process scale-up, and production operations. He leads the transition of products from research and development into commercial manufacturing, ensuring efficient production, consistent product quality, and full regulatory compliance. Core expertise: Technology transfer and process scale-up for commercial pharmaceutical production GMP-compliant manufacturing and quality assurance Troubleshooting and optimizing large-scale production operations Ensuring lab formulations are manufacturable at scale without compromising safety or performance Regulatory compliance and documentation for manufacturing readiness Muhamudu delivers practical manufacturing solutions that reduce time-to-market, improve yield, and maintain regulatory standards. Ideal for pharmaceutical companies seeking a seasoned professional to manage commercialization, scale-up projects, and operational excellence.